Evaluation of Stress and Associated Biochemical Changes in Patients With type 2 Diabetes Mellitus and Obesity

Jamia Hamdard UNiversity0 个研究点目标入组 158 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1.Patients who have given written informed consent for study participation
•2.Males and females patients aged >18 years and <65 years (both inclusive)
•3.Patients having diagnosis of type 2 diabetes as defined by American Diabetes Association (ADA 2015) criteria i.e., Hb1Ac Ã¢â?°Â¥6.5%
•4.Patients who are controlled on anti-diabetic treatment for at-least last six months
•5.Body mass index Ã¢â?°Â¥30.0 kg/m2
•6.Ability to understand study procedures and to comply with them
•Inclusion Criteria for control group:
•1.Patients who have given written informed consent for study participation
•2.Males and females patients aged >18 years and <65 years (both inclusive)
•3.Patients with no clinically significant illness and/or disease
•4.Absence of diagnosis of type 2 diabetes
•5.Absence of diagnosis of depression/anxiety or any other psychiatric disorder
•6.Ability to understand study procedures and to comply with them

•1.Patients with history or current smokers, drug or alcohol dependence
•2.Any other major psychiatric illness such as schizophrenia or mental retardation.
•3.Uncontrolled hypertension (blood pressure 180/105 mmHg or above)
•4.Patient who are already on any psychotropic drug
•5.Patient diagnosed with any psychological, behavioral disorder or severe cognitive impairment
•6.Patient with any past history of a psychiatric disorder
•7.Pregnant or breast feeding women
•8.Inability or unwillingness to give written informed consent

发起方